$8.46 0.74 (+9.59%)
11/25/2009 4:00 PM

Incyte Corp (INCY)

CAPS Rating: 3 out of 5

The Company is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs.

Featured Broker Partners